Sean F. Scanlan, SVP, Marketing at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 25,000 shares at $24.27 ($607K) on 2022-11-14, disclosed to the SEC on 2022-11-16.
Open-market sale of $607k TMCI by SVP, Marketing. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| TMCI | SELL | 2023-03-10 | $12K | — | Filing → |
| TMCI | SELL | 2023-02-17 | $542K | — | Filing → |
| TMCI | SELL | 2023-01-13 | $639K | — | Filing → |